LumiraDx (LMDX) Misses Q1 EPS by 3c

LumiraDx (NASDAQ: LMDX) reported Q1 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $126.4 million versus the consensus estimate of $113.13 million.

For earnings history and earnings-related data on LumiraDx (LMDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c